질 슬링 시장 : 유형별, 제품 유형별, 요실금 유형별, 최종사용자별, 지역별(2025-2033년)

The global vaginal slings market size reached USD 1.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.4 Billion by 2033, exhibiting a growth rate (CAGR) of 5.86% during 2025-2033.

Vaginal slings are surgeries treating stress urinary incontinence among women, which includes urine leakage caused by increased pressure in the abdomen. They help close the urethra and bladder neck with a piece of tissue or artificial mesh underneath the urethra. They offer several advantages to patients, such as a small vaginal incision, faster post-operative recovery time, and no requirement for abdominal incision and hospital stay. As a result, they are carried out in hospitals, clinics, and ambulatory surgical centers across the globe.

Vaginal Slings Market Trends:

Due to pregnancy, childbirth, and menopause, which may affect the urinary tract and surrounding muscles, there is a rise in the prevalence of stress urinary incontinence in women. This, along with the growing female geriatric population around the world, represents one of the key factors driving the market. Moreover, the rising awareness among the masses about the benefits of vaginal slings compared to conventional surgeries is contributing to the growth of the market. In addition, there is an increase in the number of hysterectomy cases due to uterine fibroids, which cause pain, bleeding, or other problems. This, coupled with the burgeoning healthcare industry, is strengthening the growth of the market. Besides this, governments of several countries are undertaking initiatives to improve healthcare infrastructure across the globe. Furthermore, the increasing number of gynecological and urological centers to cater to the demand for vaginal sling procedures is positively influencing the market. Apart from this, key market players are extensively investing in research and development (R&D) activities to introduce technologically advanced vaginal sling products, which is expected to propel the growth of the market in the coming years.

Key Market Segmentation:

Breakup by Type:

• Conventional Vaginal Slings
• Advanced Vaginal Slings

Breakup by Product Type:

• Transobturator Slings
• Tension-free Vaginal Tape Sling
• Others

Breakup by Type of Urinary Incontinence:

• Stress Urinary Incontinence
• Urge Urinary Incontinence
• Mixed Urinary Incontinence

Breakup by End User:

• Hospitals
• Ambulatory Surgery Centers
• Others

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being A.M.I. GmbH, B. Braun Melsungen AG, Betatech Medical, Boston Scientific Corporation, Caldera Medical, Coloplast A/S, Cousin Biotech, Medtronic plc, Neomedic International and Promedon GmbH.

Key Questions Answered in This Report

• 1.What was the size of the global vaginal slings market in 2024?
• 2.What is the expected growth rate of the global vaginal slings market during 2025-2033?
• 3.What are the key factors driving the global vaginal slings market?
• 4.What has been the impact of COVID-19 on the global vaginal slings market?
• 5.What is the breakup of the global vaginal slings market based on the type?
• 6.What is the breakup of the global vaginal slings market based on the product type?
• 7.What is the breakup of the global vaginal slings market based on the type of urinary incontinence?
• 8.What is the breakup of the global vaginal slings market based on the end user?
• 9.What are the key regions in the global vaginal slings market?
• 10.Who are the key players/companies in the global vaginal slings market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Vaginal Slings Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Conventional Vaginal Slings
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Advanced Vaginal Slings
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Product Type

• 7.1 Transobturator Slings
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Tension-free Vaginal Tape Sling
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Others
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Type of Urinary Incontinence

• 8.1 Stress Urinary Incontinence
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Urge Urinary Incontinence
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Mixed Urinary Incontinence
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by End User

• 9.1 Hospitals
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Ambulatory Surgery Centers
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Others
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 A.M.I. GmbH
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
  • 15.3.2 B. Braun Melsungen AG
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
    • 15.3.2.3 SWOT Analysis
  • 15.3.3 Betatech Medical
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
  • 15.3.4 Boston Scientific Corporation
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
    • 15.3.4.3 Financials
    • 15.3.4.4 SWOT Analysis
  • 15.3.5 Caldera Medical
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
  • 15.3.6 Coloplast A/S
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
    • 15.3.6.3 Financials
    • 15.3.6.4 SWOT Analysis
  • 15.3.7 Cousin Biotech
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
  • 15.3.8 Medtronic plc
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
    • 15.3.8.3 Financials
    • 15.3.8.4 SWOT Analysis
  • 15.3.9 Neomedic International
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
  • 15.3.10 Promedon GmbH
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio